Endoscopic Mini/Less Open Sublay(EMILOS) Repair

Sponsor
Diakonie-Klinikum Stuttgart (Other)
Overall Status
Completed
CT.gov ID
NCT05912868
Collaborator
(none)
174
3
90.2
58
0.6

Study Details

Study Description

Brief Summary

Ventral hernias in the midline of the abdominal wall are one of the most frequent diseases in general and visceral surgery worldwide. The optimal operative technique is still in discussion. The traditional techniques are open sublay or transabdominal intraperitoneal onlay mesh (IPOM) repair. In order to avoid the risks -large trauma to the abdominal wall with pain and infection, lesion of intraabdominal organs - a new hybrid technique - small skin incision, wide endoscopic dissection of the retrorectus space with implantation of a large mesh - was developed (EMILOS -Endoscopic Mini/Less Open Sublay).

Condition or Disease Intervention/Treatment Phase
  • Device: Endoscopic Mini/Less Open Sublay Repair

Detailed Description

Long-term results in 174 patients with a ventral hernia of the abdominal wall after EMILOS (Endoscopic Mini/Less Open Sublay) repair.

The worldwide most frequently used surgical techniques to repair ventral abdominal wall hernias are the open sublay operation and the transabdominal IPOM (Intra-Peritoneal Onlay Mesh) technique.

Therefore a special questionnaire was developed to send to the patients to evaluate long-term outcome.

Study Design

Study Type:
Observational
Actual Enrollment :
174 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Long-term Results in 174 Patients With a Ventral Hernia in the Midline of the Abdominal Wall After EMILOS (Endoscopic Mini/Less Open Sublay) Repair
Actual Study Start Date :
Jun 25, 2015
Actual Primary Completion Date :
Jan 27, 2021
Actual Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Ventral hernia repair

Endoscopic Mini/Less Open Repair

Device: Endoscopic Mini/Less Open Sublay Repair
The traditional techniques are open sublay or transabdominal intraperitoneal onlay mesh (IPOM) repair. In order to avoid the risks -large trauma to the abdominal wall with pain and infection, lesion of intraabdominal organs - a new hybrid technique - small skin incision, wide endoscopic dissection of the retrorectus space with implantation of a large mesh - was developed (EMILOS -Endoscopic Mini/Less Open Sublay).

Outcome Measures

Primary Outcome Measures

  1. Number of patients with Hernia recurrence [three years]

    prove of hernia defect and hernia sac by questionaire and clinical investigation

  2. Number of patients with bulging in the midline of abdominal wall [three years]

    Bulging without prove of a hernia defect by questionaire and clinical investigation

Secondary Outcome Measures

  1. Number of patients suffering from chronic pain [three years]

    Asking by questionaire if the patient has pain at rest and under stress in the region of the scar resp. the former hernia defect measured by numeric analog scale (NAS)

  2. Number of patients complaining about a stiff abdominal wall [three years]

    Asking by questionaire if the patient has problems to bend down and/or problems to tie shoestrings

  3. Number of patients being satisfied with operation [Three years]

    Asking by questionaire if the patient is satisfied with operation and if he would like to have this operation a second time

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria

  • Patients with clinical diagnosis of primary or secondary hernia in the midline of the abdominal wall

  • Defect size must be between 2 and 10 cm in width associated with a weak abdominal wall(rectus diastasis)

  • Patient must be suitable for general anesthesia

  • Patient must have given informed consent

  • Patient must be able to understand the principles of operation

  • Patient must agree to be incluuded in a follow-up program and to be documented in Herniamed registry

Exclusion Criteria:
  • Patients below 18 years of age

  • Patients with a defect size below 2 cm

  • Patients presenting with loss of domain

  • Patients not be able to tolerate general anesthesia

  • Patients presenting with excess skin tissue

Contacts and Locations

Locations

Site City State Country Postal Code
1 Diakonie Klinikum Stuttgart Stuttgart Baden-Württemberg Germany 70176
2 Dr.Stefan Amann Neuendettelsau Germany
3 Hernia Center Rottenburg Germany 72108

Sponsors and Collaborators

  • Diakonie-Klinikum Stuttgart

Investigators

  • Principal Investigator: Prof. Dr. med. Dr.h.c. Bittner, unaffiliated, retirement
  • Study Director: Dr. Bärbel Kraft, Diakonie-Klinikum Stuttgart
  • Study Director: Dr. Jochen Schwarz, Hernienzentrum Rottenburg
  • Study Director: Dr.Stefan Amann, Diakoneo Klinik Neudettelsau

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Diakonie-Klinikum Stuttgart
ClinicalTrials.gov Identifier:
NCT05912868
Other Study ID Numbers:
  • 1/2016
First Posted:
Jun 22, 2023
Last Update Posted:
Jun 22, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Diakonie-Klinikum Stuttgart
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 22, 2023